衰老:与自相关的病理和"痴呆症的两个面孔"
N Gammaldi1,2, S Doccini3, S Bernardi2,4
1Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Neurogenetics
|December 20, 2023
概括
神经状体脂症 (NCL) 研究揭示了儿童痴呆症中共享的分子途径. 这项研究旨在寻找针对神经退行性疾病的新疗法的常见生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 神经状体脂症 (NCL) 包括常见的儿童神经退行性疾病和儿童痴呆的主要原因.
- 了解NCL分子机制至关重要,越来越多的证据表明NCL类型的共享途径和临床特征.
- 识别病理机制,疾病修饰剂和生物标志物是开发有效NCL治疗的关键.
研究的目的:
- 该DEM-AGING项目旨在定义NCL中的分子特征,并加速生物标志物发现.
- 确定用于监测NCL疾病状态和进展的新型治疗点.
- 为了加快临床试验准备NCL和相关的神经退行性疾病.
主要方法:
- 从已建立的NCL模型中合的多原子数据与常见的晚发性神经退行性疾病的数据.
- 测试了共享分子指纹的假设,这些指纹是病理机制的基础.
- 综合数据分析,细胞模型和OMIC策略来探索治疗途径.
主要成果:
- 初步发现表明NCL和其他神经退行性疾病之间存在共同的分子特征.
- 确定了NCL进展和疾病监测的潜在生物标志物.
- 建立了一个框架,用于对神经退行症中的多原子数据进行比较分析.
结论:
- 在童年和晚期发作的神经退行性疾病之间可能存在共享的分子通路.
- 通过多分子分析发现生物标志物可以加速痴呆症的治疗发展.
- 这项研究为新的,广泛适用的痴呆症疗法提供了基础.
相关概念视频
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:36Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
01:18Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
01:15Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554